Skip to main content

Evidence-Based Supplement Research

Evidence-Based Supplement Research

Lactobacillus reuteri and Reduced Inflammatory Biomarker Level

Doses used in studies

CFU/day: 1 billion (median 1 billion, IQR 1 billion–1 billion) — 1 study

Time to effect

Median: 8 weeks · IQR 8 weeks–8 weeks · Range 8 weeks–8 weeks — Reported in 1 of 1 study

1 of 1 paper

Clinical Effects of Lactobacillus reuteri on Gingival Inflammation and Alveolar Bone Loss in Periodontitis.
- 2025-09-30
- RCT · n = 120
- Oral health & preventive dentistry 23
- - Jian Lu
  - Xiaoxiang He
  - Ting Du
  - Dongjie Fu
- PubMed: 41026095
- DOI: 10.3290/j.ohpd.c_2289
7 Insights on
- Reduced Inflammatory Biomarker Level
- High evidence
- Large Human Trial
- Clinical
IL-6 (25.84 ± 3.11 vs 14.35 ± 2.16 pg/ml, -45.2%, p 0.05)
Effect
Beneficial
Effect size
Large
Significant
Yes
Dose
1×10⁹ CFU/day